Jaka jest cena za Hancock Jaffe Laboratories (HJLI)

Cena za Hancock Jaffe Laboratories (HJLI) wynosi $10.38

Jaka jest kapitalizacja rynkowa dla Hancock Jaffe Laboratories (HJLI)

Kapitalizacja rynkowa dla Hancock Jaffe Laboratories (HJLI) wynosi $4.55M

Hancock Jaffe Laboratories (HJLI) Historia Cen

Hancock Jaffe Laboratories, Inc. is a medical device company in its developmental stage, specializing in creating advanced tissue-based and biologic solutions. These innovations are engineered to either sustain or significantly enhance the lives of patients afflicted with cardiovascular, peripheral arterial, and venous diseases, as well as end-stage renal disease (ESRD). The firm, headquartered in Irvine, California, maintains a dedicated team of nine full-time employees. Among its key initiatives, the company is actively developing implantable bioprosthetic devices for cardiovascular applications. This includes the Bioprosthetic Heart Valve (BHV), a swine-derived heart valve designed to mimic the function of a native heart valve and provide superior performance compared to current prosthetic options. Furthermore, the company is developing a Venous Valve, another bioprosthetic device sourced from pig tissue. This valve is specifically designed for individuals suffering from chronic venous insufficiency (CVI) in the lower limbs, a condition frequently resulting from damage to leg vein valves after the formation of deep venous blood clots.

Rok	Wydajność
2021	5.44%
2020	-25.89%
2019	-72.70%
2018	0.00%

Rok

Wydajność

2021

5.44%

2020

-25.89%

2019

-72.70%

2018

0.00%

Firma	Cena akcji	Zmiana 1r%	Kraj
Abbott Laboratories ABT.US	$111.15	-15.64%	US
Stryker Corporation SYK.US	$339.00	-11.24%	US
Medtronic plc MDT.US	$91.19	-1.97%	IE
Boston Scientific Corporation BSX.US	$51.77	-49.83%	US
Edwards Lifesciences Corporation EW.US	$91.49	16.90%	US

Firma

Cena akcji

Zmiana 1r%

Kraj